Minigene Splicing Assays and Long-Read Sequencing to Unravel Pathogenic Deep-Intronic Variants in
MinION nanopore sequencing
PAX6
congenital aniridia
deep-intronic variants
long-read sequencing
minigene splicing assays
non-canonical splicing sites
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
13 Jan 2023
13 Jan 2023
Historique:
received:
01
12
2022
revised:
05
01
2023
accepted:
10
01
2023
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
25
1
2023
Statut:
epublish
Résumé
PAX6 haploinsufficiency causes aniridia, a congenital eye disorder that involves the iris, and foveal hypoplasia. Comprehensive screening of the PAX6 locus, including the non-coding regions, by next-generation sequencing revealed four deep-intronic variants with potential effects on pre-RNA splicing. Nevertheless, without a functional analysis, their pathogenicity could not be established. We aimed to decipher their impact on the canonical PAX6 splicing using in vitro minigene splicing assays and nanopore-based long-read sequencing. Two multi-exonic PAX6 constructs were generated, and minigene assays were carried out. An aberrant splicing pattern was observed for two variants in intron 6, c.357+136G>A and c.357+334G>A. In both cases, several exonization events, such as pseudoexon inclusions and partial intronic retention, were observed due to the creation or activation of new/cryptic non-canonical splicing sites, including a shared intronic donor site. In contrast, two variants identified in intron 11, c.1032+170A>T and c.1033-275A>C, seemed not to affect splicing processes. We confirmed the high complexity of alternative splicing of PAX6 exon 6, which also involves unreported cryptic intronic sites. Our study highlights the importance of integrating functional studies into diagnostic algorithms to decipher the potential implication of non-coding variants, usually classified as variants of unknown significance, thus allowing variant reclassification to achieve a conclusive genetic diagnosis.
Identifiants
pubmed: 36675087
pii: ijms24021562
doi: 10.3390/ijms24021562
pmc: PMC9863980
pii:
doi:
Substances chimiques
PAX6 protein, human
0
PAX6 Transcription Factor
0
RNA Splice Sites
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Instituto de Salud Carlos III
ID : PI17/00164
Organisme : Instituto de Salud Carlos III
ID : PI20/00851
Organisme : Instituto de Salud Carlos III
ID : FI18/00123
Organisme : Instituto de Salud Carlos III
ID : CP16/00116
Organisme : Centre for Biomedical Network Research on Rare Diseases
ID : 06/07/0036
Organisme : Instituto de Salud Carlos III
ID : PT20/00141
Organisme : Fundación ONCE
ID : NA
Organisme : Comunidad de Madrid
ID : PEJD-2018-PRE/BMD-9453
Organisme : Comunidad de Madrid
ID : PEJ-2020-AI/BMD-18610
Organisme : Comunidad de Madrid
ID : PEJ-2017-AI/BMD-7256
Organisme : Autonomous University of Madrid
ID : University Chair UAM-IIS-FJD of Genomic Medicine
Références
Prog Retin Eye Res. 2022 Oct 21;:101133
pubmed: 36280537
Gene. 2017 Sep 30;630:44-48
pubmed: 28760551
Genes (Basel). 2019 Dec 17;10(12):
pubmed: 31861090
Folia Biol (Praha). 2020;66(4):123-132
pubmed: 33745259
Hum Genet. 2018 Oct;137(10):831-846
pubmed: 30291432
J Hum Genet. 2021 Mar;66(3):333-338
pubmed: 32920601
Genome Res. 2018 Jan;28(1):100-110
pubmed: 29162642
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Ophthalmology. 2016 Jun;123(6):1375-85
pubmed: 26976702
Genet Med. 2019 Aug;21(8):1751-1760
pubmed: 30643219
Arch Soc Esp Oftalmol (Engl Ed). 2021 Nov;96 Suppl 1:4-14
pubmed: 34836588
Mol Cell Probes. 1997 Aug;11(4):287-92
pubmed: 9281415
J Appl Genet. 2018 Aug;59(3):253-268
pubmed: 29680930
Prog Retin Eye Res. 2012 Sep;31(5):351-76
pubmed: 22561546
Bioessays. 2002 Nov;24(11):1041-51
pubmed: 12386935
J Med Genet. 2022 May;59(5):428-437
pubmed: 33782094
Eur J Hum Genet. 1999 Apr;7(3):274-86
pubmed: 10234503
Exp Eye Res. 2017 Mar;156:10-21
pubmed: 27126352
Hum Mutat. 2015 Feb;36(2):210-21
pubmed: 25382762
Front Cell Neurosci. 2020 Aug 20;14:265
pubmed: 32973457
Methods. 2005 Dec;37(4):331-40
pubmed: 16314262
Stem Cell Res Ther. 2021 Nov 22;12(1):581
pubmed: 34809716
Genome Med. 2022 Feb 28;14(1):23
pubmed: 35220969
Int J Mol Sci. 2021 May 13;22(10):
pubmed: 34068052
Cell Stem Cell. 2016 Jun 2;18(6):769-781
pubmed: 27151457
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Dev Biol. 2008 Jan 1;313(1):434-54
pubmed: 18062951
Front Genet. 2021 Jul 01;12:689892
pubmed: 34276790
Eur J Hum Genet. 2019 Mar;27(3):488-493
pubmed: 30315214
Mol Vis. 2012;18:751-7
pubmed: 22509105
Bioinformatics. 2005 May 1;21(9):1859-75
pubmed: 15728110
Stem Cell Res. 2021 Mar;51:102184
pubmed: 33524672
Genome Biol. 2015 Sep 30;16:204
pubmed: 26420219
Cells. 2022 Nov 06;11(21):
pubmed: 36359912
Methods Mol Biol. 2022;2434:245-255
pubmed: 35213022
Nucleic Acids Res. 2009 May;37(9):e67
pubmed: 19339519
Stem Cell Res. 2019 Dec;41:101611
pubmed: 31707209
Transl Res. 2015 Dec;166(6):740-749.e1
pubmed: 26364624
Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2581-90
pubmed: 19218613
J Appl Genet. 2018 May;59(2):151-159
pubmed: 29460221
Prog Retin Eye Res. 2021 Jul;83:100918
pubmed: 33130253
Sci Rep. 2016 Aug 24;6:31602
pubmed: 27554526
Hum Mol Genet. 1993 Jul;2(7):915-20
pubmed: 8364574
Eur J Hum Genet. 2012 Oct;20(10):1011-7
pubmed: 22692063
BMC Genet. 2005 May 26;6:27
pubmed: 15918896